Innovative drug infusion technology for laboratory animals.

Japanese English
SMP-310R SMP-200 null null null null null null null null


  • EventUnprecedented PK-PD correlations in-Vivo Pharmacology Learn how Christian Schnell, Associate Director Oncology NIBR, Novartis Pharma AG, Basel, CH reached his conclusions. Now available on demand. Registration for access < here >.

    June 21, 2021

  • EventHave you ever wanted to get more out of your in-vivo pharmaceutical studies? Have a burning question about programmable pumps and implication of refinement and reduction of animal use? Join Christian Schnell in his upcoming webinar on Programmable pumps for compounds delivery in oncology research: implication for refinement and reduction of animal use. More information and registration < here >

    May 17, 2021

  • NewsiPRECIO Programmable Minipumps for continuous delivery lenalidomide (LLD) in chronic lymphocytic leukemia (CLL). Video, from Start to 7 minutes: Rodent Studies of PK, Safety and Tolerability of LLD in Healthy and SCID Mice by Dr Jamie Oliver Chief Medical Officer of Starton Therapeutics ( IMS/SMP-300 for mice or larger used. Photo of SMP-200 for rats of larger shown.

    February 24, 2021

  • NewsNew review article on iPRECIO® - Linkedin Article – “Programmable pumps offer precise and translatable delivery of compounds to stress-free animals”

    February 9, 2021

  • NewsUS20200330445A1: Continuous delivery of lenalidomide and other immunomodulatory agents
    "After the tumor reached an average size of 100-150 mm, iPrecio pump was surgically implanted into each of the mice . Dosing began twenty - four hours post pump implantation. Each of Groups 3-6 was treated lenalidomide via continuous subcutaneous infusion at different hourly rate. The dosing lasted 14 days followed by one day off the treatment and lasted for another 14 days . The iPrecio pump was replaced after 14 days." For full reference: - Click -

    December 1, 2020


Our Mission with
iPRECIO® Product Portfolio:

Make it as easy as possible to evaluate efficacy of molecules/agents in different animal models and species.

Make the results as relevant as possible to the clinic. (Exposure profile, quantitative pharmacology, untethered free moving (stress free, group housing (socialization), ..…)

The use of iPRECIO® pumps will have a positive impact on experimental conditions and the relevance of results achieved. Initial costs maybe higher but in the long run the use of the pump could be cost saving in the context of the whole compound development.

insidescientific e-book insidescientific insidescientific qanda

Page top

Privacy Policy